Company Overview

PRIME exits and American Healthcare Capital are proud to exclusively represent a growing digital therapeutic company. This innovative digital health company is redefining chronic disease prevention and management through its scalable, evidence-based therapeutic solutions. With a strong focus on accessibility, engagement, and AI-driven automation, this company has successfully partnered with public health departments, hospitals, and corporate wellness programs to expand its reach.

Financial Overview

Over the past three years, the company has demonstrated remarkable revenue growth organically, increasing from $688,964 in 2022 to $918,152 in 2024, with steady profitability. Backed by significant industry recognition and key strategic partnerships, the company is well-positioned to expand into new markets and integrate advanced AI capabilities into its offerings.

Asking Price

The founders are open to a majority sale and rolled equity to accelerate the company’s growth and enhance its market share. With an asking price of $6,000,000 plus an earn-out, this opportunity presents an attractive investment in a rapidly growing sector. Investors looking for an established player with proven traction and a clear roadmap for expansion are invited to engage in further discussions.